| |
Potent Activity of Bictegravir (BIC; GS-9883), a Novel Unboosted HIV-1 Integrase Strand
Transfer Inhibitor (INSTI), Against Patient Isolates with INSTI-Resistance [2]
|
| |
| |
Reported by Jules Levin
14th European Workshop on HIV & Hepatitis
May 25-27, 2016
Rome, Italy
Kirsten White, Tomas Cihlar and Michael D. Miller
Gilead Sciences, Foster City, CA
|
|
| |
| |
|
|
|
